drugset / Trial / NCT03250507
Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this study is to evaluate the effectiveness of different formulations of bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain management after open abdominal hysterectomy.
Timeline
- Start
- 2017-03-13
- Primary completion
- 2019-01-30
- Completion
- 2019-01-30
Outcome
Missed primary endpoint
paper and 51 [24-84] min in group mixture (P = 0.20). PMID 33432496 ↗
paper 203 [153-283] mg in group liposomal, and 202 [116-325] mg in group mixture (P = 0.92). PMID 33432496 ↗
paper mixture of liposomal bupivacaine with plain bupivacaine for TAP block did not improve analgesia compared with either liposomal bupivacaine or plain bupivacaine PMID 33432496 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 40 ml | Other |
| Subject | Bupivacaine | Other / unclassified | 60 ml | Other |
Indications
No indication recorded.